Therapeutics

Redefining the battle against Alzheimer’s with tau-focused treatments

by
Redefining the battle against Alzheimer’s with tau-focused treatments

In a recent article published in the journal Nature Reviews Neurology, researchers discuss the efficacy of tau-targeting Alzheimer’s disease (AD) therapies and strategies that can be implemented to improve these treatments, especially immunotherapies. Study: Tau-targeting therapies for Alzheimer disease: Current status and future directions. Image Credit: Gorodenkoff / Shutterstock.com Background Since 2018, the prevalence of AD has increased … Read more

The use of artificial intelligence and natural language processing for mental health interventions

by
The use of artificial intelligence and natural language processing for mental health interventions

In a recent article published in Translational Psychiatry, researchers performed a systemic review and meta-analysis of scientific papers using an artificial intelligence (AI)-based tool that uses Natural Language Processing (NLP) to examine mental health interventions (MHI). Study: Natural language processing for mental health interventions: a systematic review and research framework. Image Credit: MMD Creative/Shutterstock.com Background Globally, neuropsychiatric disorders, such as … Read more

Drug combo safely decreases pancreatic cancer growth in mice

by
Drug combo safely decreases pancreatic cancer growth in mice

A new combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a new study finds. Led by researchers at NYU Grossman School of Medicine, its Department of Radiation Oncology, and the Perlmutter Cancer Center, the work builds on prior discoveries at NYU Langone that revealed … Read more

Research could lead to the development of new weight-loss drug that mimics exercise

by
Research could lead to the development of new weight-loss drug that mimics exercise

A brand-new kind of drug, tested in mice, shows promising new results that could lead to the development of a new weight-loss drug that mimics exercise. The new compound, developed and tested by a University of Florida professor of pharmacy and his colleagues, leads obese mice to lose weight by convincing the body’s muscles that … Read more

New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

by
New consensus statement provides guidance for use of 177Lu-PSMA radionuclide therapy in mCRPC patients

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with 177Lu-PSMA radionuclide therapy. The statement, published in the July issue of The Journal of Nuclear Medicine, also reviews current clinical struggles … Read more

Multipronged Approach Against Alzheimer’s Disease

by
Multipronged Approach Against Alzheimer’s Disease

In July 2023, Eisai and Biogen received full traditional approval from the United States Food and Drug Administration (US FDA) for their Alzheimer’s drug Leqembi (lecanemab-irmb). This drug is the first to target the disease’s progression rather than merely addressing its symptoms. The approval has infused excitement and hope into the field of Alzheimer’s drug … Read more